Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital

被引:9
|
作者
Zhang, Di [1 ]
Cui, Kai [2 ]
Wang, Taotao [1 ]
Shan, Yuanyuan [1 ]
Dong, Haiyan [1 ]
Feng, Weiyi [1 ]
Ma, Chen [1 ,3 ]
Dong, Yalin [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Pharm, Yanta West Rd 277, Xian 710061, Shaanxi, Peoples R China
[2] Xian Univ Posts & Telecommun, Dept Management Econ, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian, Shaanxi, Peoples R China
来源
关键词
Pseudomonas aeruginosa; carbapenem resistantance; risk factors; mortality; ANTIMICROBIAL RESISTANCE; BACTEREMIA; ENTEROBACTERIACEAE; SELECTION;
D O I
10.3855/jidc.10150
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is rapidly emerging as a life-threatening nosocomial infection. In this study, we aimed to identify risk factors, especially antibiotic use and co-carriage with other bacteria for CRPA infection or colonization. Methodology: A retrospective study was conducted in the First Affiliated Hospital of Xi'an Jiaotong University, which involved a cohort of patients with Pseudomonas aeruginosa infection or colonization from January 2014 to June 2016. Univariate analysis and multivariate analysis were performed to estimate the risk factors of CRPA occurrence. Results: Eight hundred and eighty-eight patients were included in the study. More than 50% of the risk factors were associated with CRPA infection or colonization according to univariate analysis (P < 0.05), such as invasive procedures, co-carriage with Gram-negative pathogens, and prior treatment with some antibiotics. However, only prior exposure to carbapenems (OR: 8.005; CI: 4.507-14.217, P < 0.001), the days of carbapenems treatment (OR: 1.190; CI: 1.073-1.272; P < 0.001), and co-carriage with Escherichia coli (OR: 1.824; CI: 1.005-3.310, P = 0.048) were considered independent risk factors by multivariate analysis. A higher mortality was found among patients with CRPA infection or colonization (P < 0.05). Conclusions: Risk factors for CRPA infection or colonization were prior exposure to carbapenems, the days of carbapenems treatment, and co-carriage with Escherichia coli. The prevalence of CRPA could be influenced by Gram-negative pathogens, especially in Escherichia coli, and it need more researches. Moreover, restrictions in the clinical use of carbapenems should be taken into account.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 50 条
  • [21] Characterization of carbapenem-resistant Pseudomonas aeruginosa in a university hospital, United States
    Palavecino, Elizabeth
    Kilic, Abdullah
    INFECTIOUS DISEASES, 2021, 53 (05) : 396 - 398
  • [22] Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
    Sophonsri, Anthony
    Kelsom, Corey
    Lou, Mimi
    Nieberg, Paul
    Wong-Beringer, Annie
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [23] Associations between Carbapenem Use, Carbapenem-Resistant Pseudomonas aeruginosa, and Carbapenem-Resistant Acinetobacter baumannii
    Apisarnthanarak, Anucha
    Jitpokasem, Sumana
    Mundy, Linda M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (11): : 1235 - 1237
  • [24] Colonization pressure as a risk factor for colonization by multiresistant Acinetobacter spp and carbapenem-resistant Pseudomonas aeruginosa in an intensive care unit
    DalBen, Mirian Freitas
    Basso, Mariusa
    Garcia, Cilmara Polido
    Costa, Silvia Figueiredo
    Toscano, Cristiana Maria
    Jarvis, William Robert
    Lobo, Renata Desordi
    Oliveira, Maura Salaroli
    Levin, Anna Sara
    CLINICS, 2013, 68 (08) : 1128 - 1133
  • [25] Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients
    Pettigrew, Melinda M.
    Gent, Janneane F.
    Kong, Yong
    Halpin, Alison Laufer
    Pineles, Lisa
    Harris, Anthony D.
    Johnson, J. Kristie
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (04) : 604 - 613
  • [26] Carbapenem-resistant Enterobacteriaceae in hematological patients: Outcome of patients with Carbapenem-resistant Enterobacteriaceae infection and risk factors for progression to infection after rectal colonization
    Zhang, Lining
    Zhai, Weihua
    Lin, Qingsong
    Zhu, Xiaofan
    Xiao, Zhijian
    Yang, Renchi
    Zheng, Yizhou
    Zhang, Fengkui
    Li, Shangzhu
    Wang, Chuan
    Feng, Sizhou
    Han, Mingzhe
    Wang, Jianxiang
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (04) : 527 - 529
  • [27] Virulence Factors Of Carbapenem-Resistant Pseudomonas aeruginosa In Hospital-Acquired Infections In Mansoura, Egypt
    El-Mahdy, Rasha
    El-Kannishy, Ghada
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 3455 - 3461
  • [28] Challenges of Carbapenem-resistant Pseudomonas aeruginosa in Infection Control and Antibiotic Management
    Kim, Young Jin
    Huh, Hee Jae
    Sung, Heungsup
    ANNALS OF LABORATORY MEDICINE, 2024, 44 (01) : 1 - 2
  • [29] Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa
    Pakyz, Amy L.
    Oinonen, Michael
    Polk, Ronald E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1983 - 1986
  • [30] The trend of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in a regional teaching hospital from 2012 to 2016
    Chu, Yuan-Hsin
    Huang, Yi-Ching
    Liu, Fang-Ching
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S221 - S222